Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,200 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 July 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 185 pages)

 

Export 2278 results:
Author Title Type [ Year(Desc)]
1988
G. Hall, Luscombe, D. K., and Walker, S. R., “Post-marketing surveillance using a computerised general practice data base”, Pharmaceutical Medicine, vol. 2, pp. 345-351, 1988.
1990
H. Jick, Hall, G. C., Dean, A. D., Jick, S. S., and Derby, L. E., “A comparison of the risk of hypoglycemia between users of human and animal insulins. 1. Experience in the United Kingdom”, Pharmacotherapy, vol. 10, pp. 395-7, 1990.
M. Lawrence, Coulter, A., and Jones, L., “A total audit of preventive procedures in 45 practices caring for 430,000 patients”, Bmj, vol. 300, pp. 1501-3, 1990.
1991
H. Jick, Jick, S. S., and Derby, L. E., “Validation of information recorded on general practitioner based computerised data resource in the United Kingdom”, Bmj, vol. 302, pp. 766-8, 1991.
1992
L. E. Derby, Jick, H., and Dean, A. D., “Antidepressant drugs and suicide”, J Clin Psychopharmacol, vol. 12, pp. 235-40, 1992.
S. S. Jick, Jick, H., Knauss, T. A., and Dean, A. D., “Antidepressants and convulsions”, J Clin Psychopharmacol, vol. 12, pp. 241-5, 1992.
H. Jick, Ulcickas, M., and Dean, A., “Comparison of frequencies of suicidal tendencies among patients receiving fluoxetine, lofepramine, mianserin, or trazodone”, Pharmacotherapy, vol. 12, pp. 451-4, 1992.
H. Jick, Terris, B. Z., Derby, L. E., and Jick, S. S., “Further validation of information recorded on a general practitioner based computerized data resource in the united kingdom”, Pharmacoepidemiology and Drug Safety, vol. 1, pp. 347-349, 1992.
H. Jick, Derby, L. E., Rodriguez, L. A. Garcia, Jick, S. S., and Dean, A. D., “Liver disease associated with diclofenac, naproxen, and piroxicam”, Pharmacotherapy, vol. 12, pp. 207-12, 1992.
R. N. Wild, “Micturin and torsades de pointe — experience of a post‐marketing alert”, vol. 1, pp. 147 - 150, 1992.
S. Mannino, Garcia-Rodriguez, L. A., and Jick, S. S., “NSAIDs, quinolones and convulsions: An epidemiologic approach”, vol. 6, pp. 119-128, 1992.
R. D. Mann, Hall, G., and Chukwujindu, J., “Research implications of computerised primary care”, Post Marketing Surveillance, vol. 5, pp. 259-268, 1992.
J. D. Orlander, Jick, S. S., Dean, A. D., and Jick, H., “Urinary tract infections and estrogen use in older women”, J Am Geriatr Soc, vol. 40, pp. 817-20, 1992.
1993
I. Nazareth, King, M., Haines, A., Rangel, L., and Myers, S., “Accuracy of diagnosis of psychosis on general practice computer system”, Bmj, vol. 307, pp. 32-4, 1993.
I. Nazareth, King, M., Haines, A., Tai, S. S., and Hall, G., “Care of schizophrenia in general practice”, Bmj, vol. 307, p. 910, 1993.
L. E. Derby, Jick, H., Henry, D. A., and Dean, A. D., “Cholestatic hepatitis associated with flucloxacillin”, Med J Aust, vol. 158, pp. 596-600, 1993.
Y. Lis, Spitzer, W. O., Mann, R. D., Chukwujindu, J., Thorogood, M., Evans, S., Suissa, S., and Lelorier, J., “A concurrent cohort study of oral contraceptive users from the VAMP research bank”, Pharmacoepidemiology and Drug Safety, vol. 2, pp. 51-63, 1993.
L. E. Derby, Jick, H., Henry, D. A., and Dean, A. D., “Erythromycin-associated cholestatic hepatitis”, Med J Aust, vol. 158, pp. 600-2, 1993.
S. S. Jick, Jick, H., and Dean, A. D., “A follow-up safety study of ciprofloxacin users”, Pharmacotherapy, vol. 13, pp. 461-4, 1993.
L. E. Derby, Gutthann, S. P., Jick, H., and Dean, A. D., “Liver disorders in patients receiving chlorpromazine or isoniazid”, Pharmacotherapy, vol. 13, pp. 353-8, 1993.
G. C. Hall, Chukwujindu, J., Richardson, J., Lis, Y., and Wild, R. N., “Micturin (Terodiline Hydrochloride), Torsades de Pointe and other Arrhythmias — A Study using the VAMP Database”, Pharmacoepidemiology and Drug Safety, vol. 2, pp. 127-132, 1993.
H. Jick, Derby, L. E., Rodriguez, L. A. Garcia, Jick, S. S., and Dean, A. D., “Nonsteroidal antiinflammatory drugs and certain rare, serious adverse events: a cohort study”, Pharmacotherapy, vol. 13, pp. 212-7, 1993.
D. J. Sleator, “Towards accurate prescribing analysis in general practice: accounting for the effects of practice demography”, Br J Gen Pract, vol. 43, pp. 102-6, 1993.
1994
L. A. Garcia Rodriguez, Williams, R., Derby, L. E., Dean, A. D., and Jick, H., “Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors”, Arch Intern Med, vol. 154, pp. 311-6, 1994.
H. Jick, Derby, L. E., Dean, A. D., and Henry, D. A., “Flucloxacillin and cholestatic hepatitis”, Med J Aust, vol. 160, p. 525, 1994.
F. DM, “Practice based information systems for monitoring medicines”, Pharmaceutical Medicine, vol. 8, pp. 161-176, 1994.
T. - P. Van Staa and Abenhaim, L., “The quality of information recorded on a UK database of primary care records: A study of hospitalizations due to hypoglycemia and other conditions”, Pharmacoepidemiology and Drug Safety, vol. 3, pp. 15-21, 1994.
L. A. Garcia Rodriguez and Jick, H., “Risk of gynaecomastia associated with cimetidine, omeprazole, and other antiulcer drugs”, Bmj, vol. 308, pp. 503-6, 1994.
L. A. Garcia Rodriguez and Jick, H., “Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs”, Lancet, vol. 343, pp. 769-72, 1994.
R. D. Mann, Lis, Y., Chukwujindu, J., and Chanter, D. O., “A study of the association between hormone replacement therapy, smoking and the occurrence of myocardial infarction in women”, J Clin Epidemiol, vol. 47, pp. 307-12, 1994.
S. J. Roberts and Bateman, D. N., “The use of nitrates, calcium channel blockers and ACE inhibitors in primary care in the Northern Region: a pharmacoepidemiological study”, Br J Clin Pharmacol, vol. 38, pp. 489-97, 1994.
R. D. Mann, “The VAMP system and the detection of risk, some examples”, Pharmacoepidemiology and Drug Safety, vol. 3, pp. 313-319, 1994.
1995
S. S. Jick, Dean, A. D., and Jick, H., “Antidepressants and suicide”, Bmj, vol. 310, pp. 215-8, 1995.
I. Nazareth, King, M., and Davies, S., “Care of schizophrenia in general practice: the general practitioner and the patient”, Br J Gen Pract, vol. 45, pp. 343-7, 1995.
T. Lancaster, Surman, G., Lawrence, M., Mant, D., Vessey, M., Thorogood, M., Yudkin, P., and Daly, E., “Hormone replacement therapy: characteristics of users and non-users in a British general practice cohort identified through computerised prescribing records”, J Epidemiol Community Health, vol. 49, pp. 389-94, 1995.
H. Jick and Derby, L. E., “A large population-based follow-up study of trimethoprim-sulfamethoxazole, trimethoprim, and cephalexin for uncommon serious drug toxicity”, Pharmacotherapy, vol. 15, pp. 428-32, 1995.
L. A. Garcia Rodriguez, Mannino, S., and Wallander, M. A., “Ocular safety of antiulcer drugs”, Lancet, vol. 345, pp. 1059-60, 1995.
H. Jick, Jick, S. S., Gurewich, V., Myers, M. W., and Vasilakis, C., “Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components”, Lancet, vol. 346, pp. 1589-93, 1995.
H. Jick, Myers, M. W., and Dean, A. D., “The risk of sulfasalazine- and mesalazine-associated blood disorders”, Pharmacotherapy, vol. 15, pp. 176-81, 1995.
D. C. Lloyd, Harris, C. M., and Roberts, D. J., “Specific therapeutic group age-sex related prescribing units (STAR-PUs): weightings for analysing general practices' prescribing in England”, Bmj, vol. 311, pp. 991-4, 1995.
1996
L. A. Garcia Rodriguez, Mannino, S., Wallander, M. A., and Lindblom, B., “A cohort study of the ocular safety of anti-ulcer drugs”, Br J Clin Pharmacol, vol. 42, pp. 213-6, 1996.
S. Turnbull, Ward, A., Treasure, J., Jick, H., and Derby, L., “The demand for eating disorder care. An epidemiological study using the general practice research database”, Br J Psychiatry, vol. 169, pp. 705-12, 1996.
L. A. Garcia Rodriguez, Stricker, B. H., and Zimmerman, H. J., “Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid”, Arch Intern Med, vol. 156, pp. 1327-32, 1996.
H. Jick, Derby, L. E., Gurewich, V., and Vasilakis, C., “The risk of myocardial infarction associated with antihypertensive drug treatment in persons with uncomplicated essential hypertension”, Pharmacotherapy, vol. 16, pp. 321-6, 1996.
L. E. Derby, Tennis, P., and Jick, H., “Sudden unexplained death among subjects with refractory epilepsy”, Epilepsia, vol. 37, pp. 931-5, 1996.
S. Donovan, “The Use of the General Practice Research Database (Gprd) to Examine Potential Links between Antidepressant Medication and the Incidence of Suicide”, Drug Information Journal, vol. 30, pp. 785-792, 1996.
D. Henry, Lim, L. L., Rodriguez, L. A. Garcia, S. Gutthann, P., Carson, J. L., Griffin, M., Savage, R., Logan, R., Moride, Y., Hawkey, C., Hill, S., and Fries, J. T., “Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis”, Bmj, vol. 312, pp. 1563-6, 1996.
1997
A. M. Walker, Szneke, P., Bianchi, L. A., Field, L. G., Sutherland, L. R., and Dreyer, N. A., “5-Aminosalicylates, sulfasalazine, steroid use, and complications in patients with ulcerative colitis”, Am J Gastroenterol, vol. 92, pp. 816-20, 1997.
S. S. Jick and Terris, B. Z., “Anticonvulsants and congenital malformations”, Pharmacotherapy, vol. 17, pp. 561-4, 1997.
H. Jick, Vasilakis, C., and Derby, L. E., “Antihypertensive drugs and fatal myocardial infarction in persons with uncomplicated hypertension”, Epidemiology, vol. 8, pp. 446-8, 1997.
[Page last reviewed 4 July 2019]